Skip to main content
Figure 1 | Respiratory Research

Figure 1

From: Inhaled tolafentrine reverses pulmonary vascular remodeling via inhibition of smooth muscle cell migration

Figure 1

Immediate vasodilatory effects of inhaled tolafentrine in monocrotaline-induced pulmonary arterial hypertension. Monocrotaline (MCT[28d]) treated animals received tolafentrine over an inhalation period of 5 min subsequent to catheterization. The decrease in right ventricular systolic pressure (RVSP, in mmHg) and systemic arterial pressure (SAP, in mmHg) in response to the vasodilatory treatment is given. All values are given as mean ± SEM. *, p < 0.05 versus non treated animals

Back to article page

Respiratory Research

ISSN: 1465-993X

Contact us